Start with a single vial, assess tolerance, and then consider a full course kit
Water retention, hormonal fluctuations, and the timing of your last meal can swing the number by several pounds in either direction
Hims and other companies have taken to offering personalized dosages and formulations for certain patients, arguing they offer extra benefits
In August 2025, SC Wegovy became the first GLP-1 to be approved for metabolic dysfunction-associated steatohepatitis (MASH)
It then inhibits adipocyte lipolysis and increases FFAs in cells, further stimulating the LDLs accumulation and secretion, inducing lipid metabolism disorders, lipotoxicity, and even cell necrosis, finally resulting in diabetic myocardial damage